Use of peripheral blood DNA for genotype antiretroviral resistance testing in drug-naive HIV-infected subjects

被引:27
作者
Vicenti, Ilaria [1 ]
Razzolini, Francesca [1 ]
Saladini, Francesco [1 ]
Romano, Laura [1 ]
Zazzi, Maurizio [1 ]
机构
[1] Univ Siena, Dept Mol Biol, Policlin Le Scotte, Microbiol Sect, I-53100 Siena, Italy
关键词
D O I
10.1086/518287
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Parallel analysis of peripheral blood mononuclear cell DNA and plasma RNA from 169 drug-naive human immunodeficiency virus-infected subjects revealed that evaluation of both compartments increases the sensitivity of detection of drug resistance-related mutations, compared with examination of either source alone. Peripheral blood mononuclear cell DNA may play a role in the surveillance of transmitted antiretroviral resistance.
引用
收藏
页码:1657 / 1661
页数:5
相关论文
共 12 条
[1]   HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time [J].
Ghosn, J ;
Pellegrin, I ;
Goujard, C ;
Deveau, C ;
Viard, JP ;
Galimand, J ;
Harzic, M ;
Tamalet, C ;
Meyer, L ;
Rouzioux, C ;
Chaix, ML .
AIDS, 2006, 20 (02) :159-170
[2]  
Johnson Victoria A, 2006, Top HIV Med, V14, P125
[3]   Evaluation of dried blood spots for human immunodeficiency virus type 1 drug resistance testing [J].
McNulty, Amanda ;
Jennings, Cheryl ;
Bennett, Diane ;
Fitzgibbon, Joseph ;
Bremer, James W. ;
Ussery, Michael ;
Kalish, Marcia L. ;
Heneine, Walid ;
Garcia-Lerma, J. Gerardo .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (02) :517-521
[4]   Multiple, linked human immunodeficiency virus type 1 drug resistance mutations in treatment-experienced patients are missed by standard genotype analysis [J].
Palmer, S ;
Kearney, M ;
Maldarelli, F ;
Halvas, EK ;
Bixby, CJ ;
Bazmi, H ;
Rock, D ;
Falloon, J ;
Davey, RT ;
Dewar, RL ;
Metcalf, JA ;
Hammer, S ;
Mellors, JW ;
Coffin, JM .
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (01) :406-413
[5]   Performance of an in-house genotypic antiretroviral resistance assay in patients pretreated with multiple human immunodeficiency virus type 1 protease and reverse transcriptase inhibitors [J].
Peduzzi, C ;
Pierotti, P ;
Venturi, G ;
Romano, L ;
Mazzotta, F ;
Zazzi, M .
JOURNAL OF CLINICAL VIROLOGY, 2002, 25 (01) :57-62
[6]   HIV-1 dynamics in vivo: Virion clearance rate, infected cell life-span, and viral generation time [J].
Perelson, AS ;
Neumann, AU ;
Markowitz, M ;
Leonard, JM ;
Ho, DD .
SCIENCE, 1996, 271 (5255) :1582-1586
[7]   HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance [J].
Shafer, Robert W. ;
Rhee, Soo-Yon ;
Pillay, Deenan ;
Miller, Veronica ;
Sandstrom, Paul ;
Schapiro, Jonathan M. ;
Kuritzkes, Daniel R. ;
Bennett, Diane .
AIDS, 2007, 21 (02) :215-223
[8]  
Vandamme AM, 2004, ANTIVIR THER, V9, P829
[9]  
Venturi G, 2002, ANTIVIR THER, V7, P245
[10]   Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe:: Implications for clinical management [J].
Wensing, AMJ ;
van de Vijver, DA ;
Angarano, G ;
Asjo, B ;
Balotta, C ;
Boeri, E ;
Camacho, R ;
Chaix, ML ;
Costagliola, D ;
De Luca, A ;
Derdelinckx, I ;
Grossman, Z ;
Hamouda, O ;
Hatzakis, A ;
Hemmer, R ;
Hoepelman, A ;
Horban, A ;
Korn, K ;
Kücherer, C ;
Leitner, T ;
Loveday, C ;
MacRae, E ;
Maljkovic, I ;
de Mendoza, C ;
Meyer, L ;
Nielsen, C ;
de Coul, ELO ;
Ormaasen, V ;
Paraskevis, D ;
Perrin, L ;
Puchhammer-Stockl, E ;
Ruiz, L ;
Salminen, M ;
Schmit, JC ;
Schneider, F ;
Schuurman, R ;
Soriano, V ;
Stanczak, G ;
Stanojevic, M ;
Vandamme, AM ;
Van Laethem, K ;
Violin, M ;
Wilbe, K ;
Yerly, S ;
Zazzi, M ;
Boucher, CA .
JOURNAL OF INFECTIOUS DISEASES, 2005, 192 (06) :958-966